|
|
|
|
|
by carbocation
834 days ago
|
|
One related publication that I thought would have fit well into the comment about disparate pain treatment is this[1] from Ziad Obermeyer's group. They found that when they trained a model using patient pain and knee X-rays, much of the disparity in symptoms could be accounted for by findings from the X-rays themselves. It's a nice example of where using the patients' symptoms and objective data may actually outperform current medical standards, which fits with her participatory comments in the final paragraph. 1 = https://www.nature.com/articles/s41591-020-01192-7 |
|
I think you’re jumping the gun here, this paper was a hot topic when it was published. Patient symptoms combined with objective data is already the medical standard.
Note that:
1. KLG is not a measure of pain but of OA radiographic severity.
2. KLG 3-4 is not a prerequisite for surgery.
From the article:
> While radiographic severity is not part of the formal guideline in allocations for arthroplasty (which only requires evidence of radiographic damage), empirically, patients with higher KLGs are more likely to receive surgery.
TKA patients skew to higher grade for many reasons, one being that studies have shown KLG 2 patients who undergo TKA are more likely to experience dissatisfaction (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344222/).
There are a lot of “ifs” in this paper which did not examine whether KLG 1-2 but ALG-P 3-4 patients benefit from TKA over conservative mgmt or other surgical interventions. It’s also unclear whether this better selects patients for TKA than KLG 1-2 + pain scores and other clinical variables.
All this shows is that KLG is a poor correlate for pain, which is known and not what the score is designed/used for.